These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26084332)

  • 21. Comparative Pharmacology and Guide to the Use of the Serotonin 5-HT
    Kovac AL
    Drugs; 2016 Dec; 76(18):1719-1735. PubMed ID: 27988869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacy of three 5-HT3 antagonists (granisetron, ondansetron, and tropisetron) plus dexamethasone for the prevention of cisplatin-induced acute emesis: a randomized crossover study.
    Chua DT; Sham JS; Kwong DL; Kwok CC; Yue A; Foo YC; Chan R
    Am J Clin Oncol; 2000 Apr; 23(2):185-91. PubMed ID: 10776982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dexamethasone for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomized controlled studies].
    Eberhart LH; Morin AM; Georgieff M
    Anaesthesist; 2000 Aug; 49(8):713-20. PubMed ID: 11013774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin receptor antagonists for highly emetogenic chemotherapy in adults.
    Billio A; Morello E; Clarke MJ
    Cochrane Database Syst Rev; 2010 Jan; (1):CD006272. PubMed ID: 20091591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy, safety and effectiveness of ondansetron compared to other serotonin-3 receptor antagonists (5-HT3RAs) used to control chemotherapy-induced nausea and vomiting: systematic review and meta-analysis.
    Simino GP; Marra LP; Andrade EI; Acúrcio Fde A; Reis IA; De Araújo VE; Cherchiglia ML
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1183-94. PubMed ID: 27180992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioperative antiemetic efficacy of dexamethasone versus 5-HT3 receptor antagonists: a meta-analysis and trial sequential analysis of randomized controlled trials.
    Singh PM; Borle A; Panwar R; Makkar JK; McGrath I; Trikha A; Sinha A
    Eur J Clin Pharmacol; 2018 Oct; 74(10):1201-1214. PubMed ID: 29858921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of 5-HT3 receptor antagonists in preventing postoperative nausea and vomiting.
    Board T; Board R
    AORN J; 2006 Jan; 83(1):209-16, 219-20. PubMed ID: 16528908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drugs for preventing post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: Network meta-analysis of randomized clinical trials and trial sequential analysis.
    Sridharan K; Sivaramakrishnan G
    Int J Surg; 2019 Sep; 69():1-12. PubMed ID: 31299429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials.
    Habib AS; El-Moalem HE; Gan TJ
    Can J Anaesth; 2004 Apr; 51(4):311-9. PubMed ID: 15064259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurokinin-1 receptor antagonists for postoperative nausea and vomiting: a systematic review and meta-analysis].
    Murakami C; Kakuta N; Satomi S; Nakamura R; Miyoshi H; Morio A; Saeki N; Kato T; Ohshita N; Tanaka K; Tsutsumi YM
    Braz J Anesthesiol; 2020; 70(5):508-519. PubMed ID: 32753114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone combined with other antiemetics versus single antiemetics for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: An updated systematic review and meta-analysis.
    Awad K; Ahmed H; Abushouk AI; Al Nahrawi S; Elsherbeny MY; Mustafa SM; Attia A
    Int J Surg; 2016 Dec; 36(Pt A):152-163. PubMed ID: 27793640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexamethasone, ondansetron, and their combination and postoperative nausea and vomiting in children undergoing strabismus surgery: a meta-analysis of randomized controlled trials.
    Shen YD; Chen CY; Wu CH; Cherng YG; Tam KW
    Paediatr Anaesth; 2014 May; 24(5):490-8. PubMed ID: 24612183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review.
    dos Santos LV; Souza FH; Brunetto AT; Sasse AD; da Silveira Nogueira Lima JP
    J Natl Cancer Inst; 2012 Sep; 104(17):1280-92. PubMed ID: 22911671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone for antiemesis in laparoscopic gynecologic surgery: a systematic review and meta-analysis.
    Pham A; Liu G
    Obstet Gynecol; 2012 Dec; 120(6):1451-8. PubMed ID: 23168772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent improvements in antiemetic therapy].
    Roila F; Palladino MA; Ciccarese G; Basurto C
    Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A risk-benefit assessment of serotonin 5-HT3 receptor antagonists in antineoplastic therapy-induced emesis.
    Perez EA
    Drug Saf; 1998 Jan; 18(1):43-56. PubMed ID: 9466087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.
    Singh PM; Borle A; Gouda D; Makkar JK; Arora MK; Trikha A; Sinha A; Goudra B
    J Clin Anesth; 2016 Nov; 34():459-82. PubMed ID: 27687434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomiting.
    Plosker GL; Benfield P
    Pharmacoeconomics; 1996 Apr; 9(4):357-74. PubMed ID: 10160110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.
    Phillips RS; Gopaul S; Gibson F; Houghton E; Craig JV; Light K; Pizer B
    Cochrane Database Syst Rev; 2010 Sep; (9):CD007786. PubMed ID: 20824866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.
    Jin Y; Sun W; Gu D; Yang J; Xu Z; Chen J
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):41-50. PubMed ID: 22519361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.